Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Fitzgerald

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Rheumatology (Oxford, England)|August 29, 2006
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studiesC O Bingham, A I Sebba, B R Rubin, et al.
The Journal of Biological Chemistry|June 15, 1992
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivoA Baxter, B J Fitzgerald, J L Hutson, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Rheumatology (Oxford, England)|August 29, 2006
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studiesC O Bingham, A I Sebba, B R Rubin, et al.
The Journal of Biological Chemistry|June 15, 1992
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivoA Baxter, B J Fitzgerald, J L Hutson, et al.
Pageof 3